STOCK TITAN

iHuman Inc. Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags

iHuman Inc. (NYSE: IH) reported its Q4 and FY2024 financial results, showing mixed performance. Q4 revenues decreased 7.1% to RMB232.7M (US$31.9M), with net income of RMB26.5M (US$3.6M). Average MAUs reached 25.78M, up from 25.38M year-over-year.

FY2024 highlights include revenues of RMB922.2M (US$126.3M), down 9.4% YoY, while average MAUs grew 14.9% to 26.47M. The company maintained profitability for the 12th consecutive quarter and announced a special cash dividend of US$0.10 per ADS.

The company highlighted its AI innovations, including the launch of a proprietary large language model (LLM) and integration of DeepSeek models. Notable product developments include iHuman Smart Coder and the Rainbow Crew animated series expansion. The revenue decline was attributed to China's decreasing newborn population and conservative consumer spending.

iHuman Inc. (NYSE: IH) ha riportato i risultati finanziari del Q4 e dell'anno fiscale 2024, mostrando una performance mista. I ricavi del Q4 sono diminuiti del 7,1% a RMB232,7M (US$31,9M), con un utile netto di RMB26,5M (US$3,6M). Gli utenti attivi mensili medi (MAU) hanno raggiunto i 25,78 milioni, in aumento rispetto ai 25,38 milioni dell'anno precedente.

Tra i risultati principali dell'anno fiscale 2024 si evidenziano ricavi di RMB922,2M (US$126,3M), in calo del 9,4% rispetto all'anno precedente, mentre gli MAU medi sono cresciuti del 14,9% a 26,47 milioni. L'azienda ha mantenuto la redditività per il 12° trimestre consecutivo e ha annunciato un dividendo in contante speciale di US$0,10 per ADS.

L'azienda ha messo in evidenza le sue innovazioni nell'IA, tra cui il lancio di un modello linguistico di grandi dimensioni proprietario (LLM) e l'integrazione dei modelli DeepSeek. Sviluppi di prodotto significativi includono iHuman Smart Coder e l'espansione della serie animata Rainbow Crew. Il calo dei ricavi è stato attribuito alla diminuzione della popolazione di neonati in Cina e alla spesa cauta dei consumatori.

iHuman Inc. (NYSE: IH) reportó sus resultados financieros del Q4 y del año fiscal 2024, mostrando un desempeño mixto. Los ingresos del Q4 disminuyeron un 7.1% a RMB232.7M (US$31.9M), con un ingreso neto de RMB26.5M (US$3.6M). Los usuarios activos mensuales promedio (MAU) alcanzaron 25.78 millones, un aumento respecto a los 25.38 millones del año anterior.

Los aspectos destacados del año fiscal 2024 incluyen ingresos de RMB922.2M (US$126.3M), una caída del 9.4% interanual, mientras que los MAU promedio crecieron un 14.9% a 26.47 millones. La empresa mantuvo la rentabilidad durante el duodécimo trimestre consecutivo y anunció un dividendo en efectivo especial de US$0.10 por ADS.

La empresa destacó sus innovaciones en IA, incluido el lanzamiento de un modelo de lenguaje grande (LLM) propietario y la integración de modelos DeepSeek. Los desarrollos de productos notables incluyen iHuman Smart Coder y la expansión de la serie animada Rainbow Crew. La disminución de los ingresos se atribuyó a la disminución de la población de recién nacidos en China y al gasto conservador de los consumidores.

iHuman Inc. (NYSE: IH)는 4분기 및 2024 회계연도 재무 실적을 발표하며 혼합된 성과를 보였습니다. 4분기 수익은 7.1% 감소한 RMB232.7M (미화 3,190만 달러)로, 순이익은 RMB26.5M (미화 360만 달러)입니다. 월평균 활성 사용자(MAU)는 2578만 명에 도달하여 전년 대비 25.38만 명에서 증가했습니다.

2024 회계연도 하이라이트에는 RMB922.2M (미화 1억 2630만 달러)의 수익이 포함되며, 이는 전년 대비 9.4% 감소한 수치입니다. 반면 월평균 MAU는 14.9% 증가하여 2647만 명에 달했습니다. 이 회사는 12분기 연속으로 수익성을 유지했으며, ADS당 미화 0.10달러의 특별 현금 배당금을 발표했습니다.

회사는 AI 혁신을 강조하며, 독자적인 대형 언어 모델(LLM)의 출시와 DeepSeek 모델의 통합을 포함했습니다. 주목할 만한 제품 개발로는 iHuman Smart Coder와 Rainbow Crew 애니메이션 시리즈의 확장이 있습니다. 수익 감소는 중국의 신생아 인구 감소와 보수적인 소비자 지출에 기인했습니다.

iHuman Inc. (NYSE: IH) a publié ses résultats financiers du quatrième trimestre et de l'exercice 2024, affichant des performances mitigées. Les revenus du Q4 ont diminué de 7,1 % pour atteindre 232,7 millions RMB (31,9 millions USD), avec un bénéfice net de 26,5 millions RMB (3,6 millions USD). Le nombre moyen d'utilisateurs actifs mensuels (MAU) a atteint 25,78 millions, en hausse par rapport à 25,38 millions l'année précédente.

Les points forts de l'exercice 2024 incluent des revenus de 922,2 millions RMB (126,3 millions USD), en baisse de 9,4 % par rapport à l'année précédente, tandis que le nombre moyen de MAU a augmenté de 14,9 % pour atteindre 26,47 millions. L'entreprise a maintenu sa rentabilité pour le douzième trimestre consécutif et a annoncé un dividende exceptionnel en espèces de 0,10 USD par ADS.

L'entreprise a mis en avant ses innovations en IA, y compris le lancement d'un modèle de langage de grande taille (LLM) propriétaire et l'intégration de modèles DeepSeek. Les développements de produits notables incluent iHuman Smart Coder et l'expansion de la série animée Rainbow Crew. La baisse des revenus a été attribuée à la diminution de la population de nouveau-nés en Chine et à la consommation prudente des consommateurs.

iHuman Inc. (NYSE: IH) hat seine Finanzzahlen für das vierte Quartal und das Geschäftsjahr 2024 veröffentlicht, die eine gemischte Leistung zeigen. Die Umsätze im vierten Quartal sanken um 7,1% auf RMB232,7M (US$31,9M), mit einem Nettogewinn von RMB26,5M (US$3,6M). Die durchschnittlichen monatlichen aktiven Nutzer (MAU) erreichten 25,78 Millionen, ein Anstieg von 25,38 Millionen im Vorjahr.

Die Höhepunkte des Geschäftsjahres 2024 umfassen Umsätze von RMB922,2M (US$126,3M), ein Rückgang von 9,4% im Vergleich zum Vorjahr, während die durchschnittlichen MAU um 14,9% auf 26,47 Millionen wuchsen. Das Unternehmen konnte die Rentabilität im zwölften Quartal in Folge aufrechterhalten und kündigte eine Sonderdividende von US$0,10 pro ADS an.

Das Unternehmen hob seine KI-Innovationen hervor, darunter die Einführung eines proprietären großen Sprachmodells (LLM) und die Integration von DeepSeek-Modellen. Zu den bemerkenswerten Produktentwicklungen gehören iHuman Smart Coder und die Erweiterung der animierten Serie Rainbow Crew. Der Rückgang der Einnahmen wurde auf die sinkende Geburtenrate in China und die zurückhaltenden Verbraucherausgaben zurückgeführt.

Positive
  • Maintained profitability for 12 consecutive quarters
  • 14.9% YoY growth in average total MAUs to 26.47M
  • Special cash dividend of US$0.10 per ADS announced
  • Successful launch of proprietary LLM and AI innovations
  • Strong cash position of RMB1,168.7M (US$160.1M)
Negative
  • Q4 revenues decreased 7.1% YoY to RMB232.7M
  • FY2024 revenues declined 9.4% YoY to RMB922.2M
  • Operating income dropped 55% YoY to RMB71.9M in FY2024
  • Net income decreased 45.5% YoY to RMB98.6M in FY2024
  • Gross margin declined to 67.2% in Q4 2024 from 71.2% YoY

Insights

iHuman's Q4 and FY2024 results reveal a company navigating significant headwinds while maintaining its profitability streak. The 7.1% quarterly and 9.4% annual revenue declines reflect challenging market conditions in China, specifically cited as declining birth rates and cautious consumer spending. More concerning is the substantial compression in profitability, with operating income dropping 55% year-over-year to RMB71.9 million.

Despite these challenges, several financial positives emerge. The company has delivered its 12th consecutive profitable quarter since IPO, maintaining a robust cash position of RMB1,168.7 million (US$160.1 million). The board's approval of a US$0.10 per ADS special dividend (totaling approximately US$5.2 million) signals confidence in financial stability, representing a prudent capital return while preserving substantial cash reserves for strategic investments.

The operational metrics tell an interesting story: while revenue declined, average total MAUs increased 14.9% year-over-year to 26.47 million. This divergence between user growth and revenue suggests challenges in monetization efficiency rather than product appeal. The gross margin compression (from 70.8% to 69.4%) reflects the company's strategic shift toward integrated online-offline offerings, a transition that appears to be pressuring near-term profitability metrics.

The 10.9% increase in sales and marketing expenses amid overall revenue declines indicates significant investment in growth initiatives, particularly international expansion. This strategic reallocation of resources may pressure short-term results but could diversify revenue streams beyond the challenging domestic market.

iHuman's strategic pivot toward AI-powered educational products represents a forward-thinking response to domestic market challenges. The company's early establishment of an AI Lab in 2018 and subsequent development of proprietary large language models (LLMs) positions them at the technological forefront of their industry. Their integration of DeepSeek models (V2 in May 2024, progressing to R1) demonstrates technical agility and commitment to incorporating cutting-edge AI capabilities.

The showcase product, iHuman Smart Coder, exemplifies their technical innovation strategy. By leveraging their LLM to create personalized virtual coding mentors with real-time feedback capabilities, they're transforming traditional educational content into interactive, adaptive experiences. The integration of 3D interactive blueprints and their proprietary high-intelligence controller represents significant technical differentiation in the educational technology space.

Their content expansion strategy also shows promise. The Rainbow Crew animated series commercialization demonstrates effective IP monetization, with themed merchandise extending beyond digital offerings. The rapid growth of their Two Cats IP on Red Note platform (240,000 followers and nearly 700,000 likes/saves in months) indicates effective social media channel development and content marketing capabilities.

While the company faces revenue challenges, their technical foundation and content strategy appear sound. The 14.9% MAU growth despite revenue declines suggests their product experience remains compelling. The international expansion efforts, including YouTube channel development for Rainbow Crew, represent critical diversification away from domestic demographic challenges. The question remains whether these technical investments can accelerate monetization efficiency to reverse financial trends.

BEIJING, March 25, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2024.

Fourth Quarter 2024 Highlights

  • Revenues were RMB232.7 million (US$31.9 million), compared with RMB250.4 million in the same period last year.
  • Gross profit was RMB156.4 million (US$21.4 million), compared with RMB178.2 million in the same period last year.
  • Operating income was RMB14.9 million (US$2.0 million), compared with RMB21.9 million in the same period last year.
  • Net income was RMB26.5 million (US$3.6 million), compared with RMB33.3 million in the same period last year.
  • Average total MAUs[1] for the fourth quarter were 25.78 million, compared with 25.38 million in the same period last year.

Fiscal Year 2024 Highlights

  • Revenues were RMB922.2 million (US$126.3 million), compared with RMB1,018.1 million in fiscal year 2023.
  • Gross profit was RMB640.2 million (US$87.7 million), compared with RMB721.3 million in fiscal year 2023.
  • Operating income was RMB71.9 million (US$9.9 million), compared with RMB159.9 million in fiscal year 2023.
  • Net income was RMB98.6 million (US$13.5 million), compared with RMB180.9 million in fiscal year 2023.
  • Average total MAUs were 26.47 million, compared with 23.04 million in the fiscal year 2023.

[1] "Average total MAUs" refers to the monthly average of the sum of the MAUs of each of the Company's apps during a specific period, which is counted based on the number of unique mobile devices through which such app is accessed at least once in a given month, and duplicate access to different apps is not eliminated from the total MAUs calculation.

Dr. Peng Dai, Director and Chief Executive Officer of iHuman, commented, "As we navigated evolving market conditions, we concluded 2024 with a robust and diversified product portfolio, further enhanced with more AI-integrated features that reinforces our leadership in the industry.

At the heart of our success is our long-standing dedication to technological innovation, particularly in artificial intelligence. Since establishing our AI Lab in 2018, we have consistently invested in cutting-edge advancements and seamlessly integrated them into our product offerings. By embracing transformative technologies such as AI-generated content (AIGC), we became one of the first companies in China to develop and launch a proprietary large language model (LLM), a breakthrough that now powers a comprehensive range of our offerings and elevates our user experience to new heights. Take iHuman Smart Coder as an example. Leveraging our LLM, we have transformed a traditional coding course into a highly engaging, personalized learning experience that provides real-time tailored guidance and support. Children benefit from a personalized virtual coding mentor by their side that can analyze their code, pinpoint bugs, and provide corrective feedback through features such as intuitive voice prompts, graphics, and animations, making learning more fun and accessible. Additionally, we have introduced an innovative learning framework that combines challenge-based exploration, project-driven creativity, and immersive robotics sessions. Our robotics session features a 3D interactive blueprint that enables users to visualize each step of the build, making it possible to assemble intricate robots online. Our proprietary high-intelligence controller and custom code editor further enhance the experience, allowing children to program more sophisticated and intelligent robot behaviors. Together, these innovations create a coding experience that not only inspires and engages users, but also delivers tangible outcomes. Within months of its launch, some young users successfully passed the online exam administered by the Chinese Institute of Electronics, earning the Blocks Programming Level 1 Certificate.

While pushing the boundaries of innovation from within, we also closely monitor emerging market trends, swiftly embracing new technological breakthroughs to enhance our products and maintain a competitive edge. Our early adoption of the revolutionary DeepSeek models—beginning with the V2 model in May 2024 and now fully integrating the latest R1 model across our core offerings—demonstrates our agility and forward-thinking approach. By seamlessly integrating our extensive in-house AI expertise with best-in-class third-party solutions, we deliver a more personalized, dynamic, and intelligent product experience that is tailored to each child's unique developmental needs and preferences.

As we look ahead to 2025, I am confident that our forward-thinking approach—anchored in technological excellence and creative content—will keep us at the forefront of the industry and pave the way for another promising year of growth and innovation," concluded Dr. Dai.

Ms. Vivien Weiwei Wang, Director and Chief Financial Officer of iHuman, added, "Despite facing some pressure from evolving market conditions, we are proud to report another quarter of profitability, marking our 12th consecutive quarter of positive earnings and our third consecutive year of profitability since our IPO in 2020. This consistent performance reflects the resilience of our business model and our ability to deliver sustainable growth. Meanwhile, our board of directors has approved a special cash dividend of US$0.02 per ordinary share, or US$0.10 per American Depositary Share (ADS) for the second consecutive year, which reflects our confidence in the financials and commitment to delivering shareholder value.

During the quarter, our animation studio, Kunpeng, made significant strides in both commercialization and global expansion. Capitalizing on the breakout success of the Rainbow Crew animated series, unveiled in October 2024, we introduced themed merchandise, including magic wands and stickers, with additional products currently in development. These initiatives have further enhanced the brand's presence and deepened fan engagement across multiple touchpoints. Additionally, we launched an official Rainbow Crew channel on YouTube, sharing select clips from the series. These videos have received warm feedback and strong engagement, helping build awareness among international audiences, laying the foundation for the overseas expansion of the series.

In addition to enriching our product portfolio, we have also effectively leveraged popular social media platforms to broaden our influence and expand our market reach. Our in-house IP, Two Cats (liamiao)—designed to spark interest in English and develop language awareness through engaging comics—has gained significant traction on Red Note, amassing over 240,000 followers and nearly 700,000 likes and saves in just a few months. This highlights our ability to engage audiences across diverse platforms and build meaningful connections with our users.

As we continue to make solid progress with our business, we remain focused on driving product innovation through ongoing advancements in content and technology. We are committed to translating our strategic investments into lasting value for our shareholders, users, and the broader industry."

Fourth Quarter 2024 Unaudited Financial Results

Revenues

Revenues were RMB232.7 million (US$31.9 million), a decrease of 7.1% from RMB250.4 million in the same period last year, primarily due to the decline in China's newborn population and more conservative consumer spending. 

Average total MAUs for the quarter were 25.78 million, compared with 25.38 million in the same period last year.

Cost of Revenues

Cost of revenues was RMB76.2 million (US$10.4 million), compared with RMB72.2 million in the same period last year.

Gross Profit and Gross Margin

Gross profit was RMB156.4 million (US$21.4 million), a decrease of 12.2% from RMB178.2 million in the same period last year. Gross margin was 67.2%, compared with 71.2% in the same period last year. The decrease in gross margin was mainly due to the diversification and structural upgrades of the Company's product portfolio, especially with an increased focus on the offline component of its integrated online-offline strategy to boost the overall appeal of its offerings.

Operating Expenses

Total operating expenses were RMB141.5 million (US$19.4 million), a decrease of 9.5% from RMB156.4 million in the same period last year.

Research and development expenses were RMB63.3 million (US$8.7 million), a decrease of 4.5% from RMB66.3 million in the same period last year. 

Sales and marketing expenses were RMB54.1 million (US$7.4 million), a decrease of 16.1% from RMB64.5 million in the same period last year, primarily due to strategic savings in spending on marketing activities in the fourth quarter.

General and administrative expenses were RMB24.1 million (US$3.3 million), a decrease of 5.6% from RMB25.5 million in the same period last year, primarily due to decreases in share-based compensation, as well as other administrative expenses. 

Operating Income 

Operating income was RMB14.9 million (US$2.0 million), compared with RMB21.9 million in the same period last year.

Net Income 

Net income was RMB26.5 million (US$3.6 million), compared with RMB33.3 million in the same period last year.

Basic and diluted net income per ADS were RMB0.51 (US$0.07) and RMB0.49 (US$0.07), respectively, compared with RMB0.63 and RMB0.61 in the same period last year. Each ADS represents five Class A ordinary shares of the Company.

Deferred Revenue and Customer Advances

Deferred revenue and customer advances were RMB283.3 million (US$38.8 million) as of December 31, 2024, compared with RMB318.6 million as of December 31, 2023.

Cash, Cash Equivalents and Short-term Investments

Cash, cash equivalents and short-term investments were RMB1,168.7 million (US$160.1 million) as of December 31, 2024, compared with RMB1,213.8 million as of December 31, 2023.

Fiscal Year 2024 Unaudited Financial Results

Revenues

Revenues were RMB922.2 million (US$126.3 million), a decrease of 9.4% from RMB1,018.1 million in fiscal year 2023, primarily due to the decline in China's newborn population and more conservative consumer spending.

Average total MAUs were 26.47 million, an increase of 14.9% year-over-year from 23.04 million in fiscal year 2023, primarily due to the effective execution of our user acquisition strategy, particularly with the user expansion in overseas markets. 

Cost of Revenues

Cost of revenues was RMB282.0 million (US$38.6 million), a decrease of 5.0% year-over-year from RMB296.9 million in fiscal year 2023, primarily due to decreased channel costs.

Gross Profit and Gross Margin

Gross profit was RMB640.2 million (US$87.7 million), a decrease of 11.2% from RMB721.3 million in fiscal year 2023. Gross margin was 69.4%, compared with 70.8% in fiscal year 2023. The decrease in gross margin was mainly due to the diversification and structural upgrades of the Company's product portfolio, especially with an increased focus on the offline component of its integrated online-offline strategy to boost the overall appeal of its offerings.

Operating Expenses

Total operating expenses were RMB568.2 million (US$77.8 million), compared with RMB561.4 million in fiscal year 2023.

Research and development expenses were RMB247.8 million (US$33.9 million), a decrease of 3.8% from RMB257.5 million in fiscal year 2023.

Sales and marketing expenses were RMB221.2 million (US$30.3 million), an increase of 10.9% from RMB199.5 million in fiscal year 2023, primarily due to increased strategic spending on promotional activities, brand enhancement, and overseas expansion.

General and administrative expenses were RMB99.3 million (US$13.6 million), a decrease of 4.9% from RMB104.3 million in fiscal year 2023.

Operating Income

Operating income was RMB71.9 million (US$9.9 million), compared with RMB159.9 million in fiscal year 2023.

Net Income

Net income was RMB98.6 million (US$13.5 million), compared with RMB180.9 million in fiscal year 2023.

Basic and diluted net income per ADS were RMB1.88 (US$0.26) and RMB1.82 (US$0.25), respectively, compared with RMB3.43 and RMB3.30 in fiscal year 2023. Each ADS represents five Class A ordinary shares of the Company.

Special Cash Dividend

To deliver return of capital to shareholders, the Company's board of directors (the "Board") approved a special cash dividend of US$0.02 per ordinary share, or US$0.10 per ADS, to holders of ordinary shares and holders of ADSs as of the close of business on April 17, 2025 New York Time, payable in U.S. dollars. The aggregate amount of the special dividend will be approximately US$5.2 million. The payment date is expected to be on or around May 8, 2025 and May 15, 2025 for holders of ordinary shares and holders of ADSs, respectively.

Exchange Rate Information

The U.S. dollar (US$) amounts disclosed in this press release, except for those transaction amounts that were actually settled in U.S. dollars, are presented solely for the convenience of the reader. The conversion of Renminbi (RMB) into US$ in this press release is based on the exchange rate set forth in the H.10 statistical release of the Board of Governors of the Federal Reserve System as of December 31, 2024, which was RMB7.2993 to US$1.00. The percentages stated in this press release are calculated based on the RMB amounts.

Non-GAAP Financial Measures

iHuman considers and uses non-GAAP financial measures, such as adjusted operating income, adjusted net income and adjusted diluted net income per ADS, as supplemental metrics in reviewing and assessing its operating performance and formulating its business plan. The presentation of non-GAAP financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). iHuman defines adjusted operating income, adjusted net income and adjusted diluted net income per ADS as operating income, net income and diluted net income per ADS excluding share-based compensation expenses, respectively. Adjusted operating income, adjusted net income and adjusted diluted net income per ADS enable iHuman's management to assess its operating results without considering the impact of share-based compensation expenses, which are non-cash charges. iHuman believes that these non-GAAP financial measures provide useful information to investors in understanding and evaluating the Company's current operating performance and prospects in the same manner as management does, if they so choose.

Non-GAAP financial measures are not defined under U.S. GAAP and are not presented in accordance with U.S. GAAP. Non-GAAP financial measures have limitations as analytical tools, which possibly do not reflect all items of expense that affect our operations. Share-based compensation expenses have been and may continue to be incurred in our business and are not reflected in the presentation of the non-GAAP financial measures. In addition, the non-GAAP financial measures iHuman uses may differ from the non-GAAP measures used by other companies, including peer companies, and therefore their comparability may be limited. The presentation of these non-GAAP financial measures is not intended to be considered in isolation from or as a substitute for the financial information prepared and presented in accordance with GAAP.

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Statements that are not historical facts, including statements about iHuman's beliefs and expectations, are forward-looking statements. Among other things, the description of the management's quotations in this announcement contains forward-looking statements. iHuman may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the "SEC"), in its annual report to shareholders, in press releases and other written materials, and in oral statements made by its officers, directors or employees to third parties. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: iHuman's growth strategies; its future business development, financial condition and results of operations; its ability to continue to attract and retain users, convert non-paying users into paying users and increase the spending of paying users, the trends in, and size of, the market in which iHuman operates; its expectations regarding demand for, and market acceptance of, its products and services; its expectations regarding its relationships with business partners; general economic and business conditions; regulatory environment; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in iHuman's filings with the SEC. All information provided in this press release is as of the date of this press release, and iHuman does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

About iHuman Inc.

iHuman Inc. is a leading provider of tech-powered, intellectual development products in China that is committed to making the child-upbringing experience easier for parents and transforming intellectual development into a fun journey for children. Benefiting from a deep legacy that combines over two decades of experience in the parenthood industry, superior original content, advanced high-tech innovation DNA and research & development capabilities with cutting-edge technologies, iHuman empowers parents with tools to make the child-upbringing experience more efficient. iHuman's unique, fun and interactive product offerings stimulate children's natural curiosity and exploration. The Company's comprehensive suite of innovative and high-quality products include self-directed apps, interactive content and smart devices that cover a broad variety of areas to develop children's abilities in speaking, critical thinking, independent reading and creativity, and foster their natural interest in traditional Chinese culture. Leveraging advanced technological capabilities, including 3D engines, AI/AR functionality, and big data analysis on children's behavior & psychology, iHuman believes it will continue to provide superior experience that is efficient and relieving for parents, and effective and fun for children, in China and all over the world, through its integrated suite of tech-powered, intellectual development products.

For more information about iHuman, please visit https://ir.ihuman.com/.

For investor and media enquiries, please contact:

iHuman Inc.
Mr. Justin Zhang
Investor Relations Director
Phone: +86-10-5780-6606
E-mail: ir@ihuman.com

Christensen
In China
Ms. Alice Li
Phone: +86-10-5900-1548
E-mail: alice.li@christensencomms.com 

In the US
Ms. Linda Bergkamp
Phone: +1-480-614-3004
E-mail: linda.bergkamp@christensencomms.com

iHuman Inc.

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(Amounts in thousands of Renminbi ("RMB") and U.S. dollars ("US$")

except for number of shares, ADSsper share and per ADS data)



December 31,


December 31,


December 31,


2023


2024


2024


RMB


RMB


US$







ASSETS






Current assets






Cash and cash equivalents 

1,213,767


1,123,292


153,890

Short-term investments

-


45,457


6,228

Accounts receivable, net

60,832


52,030


7,128

Inventories, net

16,518


23,475


3,216

Amounts due from related parties

1,810


2,051


281

Prepayments and other current assets

89,511


89,512


12,263

Total current assets

1,382,438


1,335,817


183,006

Non-current assets






Property and equipment, net

6,169


3,476


476

Intangible assets, net

23,245


16,429


2,251

Operating lease right-of-use assets

3,648


14,885


2,039

Long-term investment

26,333


26,333


3,608

Other non-current assets

8,662


22,701


3,110

Total non-current assets

68,057


83,824


11,484

Total assets

1,450,495


1,419,641


194,490







LIABILITIES






Current liabilities






Accounts payable

22,139


30,233


4,142

Deferred revenue and customer advances

318,587


283,251


38,805

Amounts due to related parties

4,428


1,734


238

Accrued expenses and other current liabilities

143,677


126,501


17,331

Dividend payable

-


2,164


296

Current operating lease liabilities

1,927


3,661


502

Total current liabilities

490,758


447,544


61,314

Non-current liabilities






Non-current operating lease liabilities

1,933


11,252


1,542

Total non-current liabilities

1,933


11,252


1,542

Total liabilities

492,691


458,796


62,856

SHAREHOLDERS' EQUITY






Ordinary shares (par value of US$0.0001 per share,
   700,000,000 Class A shares authorized as of
   December 31, 2023 and December 31, 2024;
   125,122,382 Class A shares issued and 119,704,787
   outstanding as of December 31, 2023; 125,122,382
   Class A shares issued and 116,084,207 outstanding as
   of December 31, 2024; 200,000,000 Class B shares
   authorized, 144,000,000 Class B ordinary shares
   issued and outstanding as of December 31, 2023 and   
   December 31, 2024; 100,000,000 shares
   (undesignated) authorized, nil shares (undesignated)
   issued and outstanding as of December 31, 2023 and   
   December 31, 2024)

185


185


25

Additional paid-in capital

1,088,628


996,657


136,541

Treasury stock

(16,665)


(26,296)


(3,603)

Statutory reserves

8,164


8,395


1,150

Accumulated other comprehensive income

17,955


24,009


3,289

Accumulated deficit

(140,463)


(42,105)


(5,768)

Total shareholders' equity

957,804


960,845


131,634

Total liabilities and shareholders' equity

1,450,495


1,419,641


194,490

 

 

iHuman Inc.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Amounts in thousands of Renminbi ("RMB") and U.S. dollars ("US$")

except for number of shares, ADSs, per share and per ADS data)



For the three months ended


For the year ended


December 31,


September 30,


December 31,


December 31,


December 31,


December 31,


December 31,


2023


2024


2024


2024


2023


2024


2024


RMB


RMB


RMB


US$


RMB


RMB


US$















Revenues

250,447


239,407


232,684


31,878


1,018,139


922,201


126,341

Cost of revenues

(72,201)


(75,541)


(76,243)


(10,445)


(296,868)


(282,048)


(38,640)















Gross profit

178,246


163,866


156,441


21,433


721,271


640,153


87,701















Operating expenses














Research and development expenses

(66,293)


(59,307)


(63,308)


(8,673)


(257,546)


(247,757)


(33,943)

Sales and marketing expenses

(64,511)


(60,863)


(54,109)


(7,413)


(199,504)


(221,230)


(30,308)

General and administrative expenses

(25,547)


(22,998)


(24,106)


(3,303)


(104,334)


(99,254)


(13,598)

Total operating expenses

(156,351)


(143,168)


(141,523)


(19,389)


(561,384)


(568,241)


(77,849)

Operating income

21,895


20,698


14,918


2,044


159,887


71,912


9,852

Other income, net

8,965


8,024


12,245


1,678


42,686


38,689


5,300

Income before income taxes

30,860


28,722


27,163


3,722


202,573


110,601


15,152

Income tax benefits (expenses)

2,411


(3,579)


(682)


(93)


(21,666)


(12,012)


(1,646)

Net income

33,271


25,143


26,481


3,629


180,907


98,589


13,506















Net income per ADS:














   - Basic

0.63


0.48


0.51


0.07


3.43


1.88


0.26

   - Diluted

0.61


0.47


0.49


0.07


3.30


1.82


0.25















Weighted average number of ADSs:














   - Basic

52,740,067


52,283,334


52,097,127


52,097,127


52,810,587


52,400,383


52,400,383

   - Diluted

54,753,503


54,011,420


53,965,183


53,965,183


54,753,025


54,239,751


54,239,751















Total share-based compensation expenses included in:














Cost of revenues

64


22


18


2


299


106


15

Research and development expenses

1,115


225


273


37


4,055


1,303


179

Sales and marketing expenses

122


39


34


5


707


164


22

General and administrative expenses

817


329


229


31


4,374


1,251


171















 

 

iHuman Inc.

UNAUDITED RECONCILIATION OF GAAP AND NON-GAAP RESULTS

(Amounts in thousands of Renminbi ("RMB") and U.S. dollars ("US$")

except for number of shares, ADSs, per share and per ADS data)




For the three months ended


For the year ended


December 31,


September 30,


December 31,


December 31,


December 31,


December 31,


December 31,


2023


2024


2024


2024


2023


2024


2024


RMB


RMB


RMB


US$


RMB


RMB


US$















Operating income

21,895


20,698


14,918


2,044


159,887


71,912


9,852

Share-based compensation expenses

2,118


615


554


75


9,435


2,824


387

Adjusted operating income

24,013


21,313


15,472


2,119


169,322


74,736


10,239















Net income

33,271


25,143


26,481


3,629


180,907


98,589


13,506

Share-based compensation expenses

2,118


615


554


75


9,435


2,824


387

Adjusted net income

35,389


25,758


27,035


3,704


190,342


101,413


13,893















Diluted net income per ADS

0.61


0.47


0.49


0.07


3.30


1.82


0.25

Impact of non-GAAP adjustments

0.04


0.01


0.01


0.00


0.18


0.05


0.01

Adjusted diluted net income per ADS

0.65


0.48


0.50


0.07


3.48


1.87


0.26















Weighted average number of ADSs – diluted

54,753,503


54,011,420


53,965,183


53,965,183


54,753,025


54,239,751


54,239,751

Weighted average number of ADSs – adjusted

54,753,503


54,011,420


53,965,183


53,965,183


54,753,025


54,239,751


54,239,751

 

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ihuman-inc-announces-fourth-quarter-and-fiscal-year-2024-unaudited-financial-results-302410361.html

SOURCE iHuman Inc.

FAQ

What are iHuman's (IH) Q4 2024 revenue and net income figures?

Q4 2024 revenues were RMB232.7M (US$31.9M), down 7.1% YoY, with net income of RMB26.5M (US$3.6M).

How much is iHuman's (IH) special cash dividend for 2024?

iHuman approved a special cash dividend of US$0.10 per ADS, payable in May 2025.

What was iHuman's (IH) user growth in fiscal year 2024?

Average total MAUs increased 14.9% to 26.47M in FY2024, up from 23.04M in FY2023.

What are the main factors affecting iHuman's (IH) 2024 revenue decline?

The revenue decline was primarily due to China's decreasing newborn population and more conservative consumer spending.

What major AI developments did iHuman (IH) announce in 2024?

iHuman launched a proprietary large language model (LLM) and integrated DeepSeek models across core offerings.
Ihuman Inc

NYSE:IH

IH Rankings

IH Latest News

IH Stock Data

107.15M
23.22M
0.67%
0.02%
Education & Training Services
Consumer Defensive
Link
China
Beijing